Skip to main content
LIGAND PHARMACEUTICALS INC logo

LIGAND PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · LGND ISIN · US53220K5048 LEI · 5493008K7TB0IKP37H79 US Financial and insurance activities
Filings indexed 1,392 across all filing types
Latest filing 2012-06-04 Director's Dealing
Country US United States of America
Listing US LGND

About LIGAND PHARMACEUTICALS INC

https://www.ligand.com/

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2012-06-04 English
8-K Filing
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated May 31, 2012. It reports on the 2012 Annual Meeting of Stockholders of Ligand Pharmaceuticals, including the approval of an amended stock incentive plan, election of directors, ratification of the independent auditor, and advisory vote on executive compensation. The key content is the submission of matters to a vote of security holders with detailed voting results. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not a full annual report, audit report, or proxy statement but specifically reports voting outcomes from the annual meeting. The length (5016 characters) and content confirm it is a voting results announcement rather than a proxy solicitation or management report.
2012-06-04 English
4 Filing
Director's Dealing
2012-06-04 English
4 Filing
Director's Dealing
2012-05-31 English
4 Filing
Director's Dealing
2012-05-31 English
4 Filing
Director's Dealing
2012-05-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.